Progyny, Inc. (PGNY)
| Market Cap | 2.16B+37.8% |
| Revenue (ttm) | n/a+5.5% |
| Net Income | n/a+48.0% |
| EPS | n/a+55.9% |
| Shares Out | 78.33M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,261,578 |
| Open | 25.81 |
| Previous Close | 25.91 |
| Day's Range | 25.81 - 28.32 |
| 52-Week Range | 16.10 - 33.07 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 35.50(+28.86%) |
| Earnings Date | n/a |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About PGNY
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PGNY stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of PGNY by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jul 30, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jul 30, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jul 29, 2020 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 30, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 30, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 29, 2020 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 1, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jun 1, 2020 |
Recently reported changes in PGNY holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PGNY's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PGNY Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PGNY Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Fertility benefits services revenue | $230.21M | 65.68% |
| Pharmacy benefits services revenue | $120.30M | 34.32% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PGNY patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PGNY from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in PGNY
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $57.56M |
| AVUVAvantis U.S. Small Cap Value ETF | $49.95M |
| IWMiShares Russell 2000 ETF | $49.70M |
| VBVanguard Morningstar Small-Cap ETF | $41.45M |
| AFTYPacer CSOP FTSE China A50 ETF | $34.08M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $23.92M |
Estimated from each fund’s disclosed top holdings × AUM
PGNY Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PGNY’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score